TEMPO/TCC as a Chemo Selective Alternative for the Oxidation of Hyaluronic Acid.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
01 Oct 2021
Historique:
received: 29 08 2021
revised: 16 09 2021
accepted: 17 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 18 11 2021
Statut: epublish

Résumé

Hyaluronic acid (HA)-based hydrogels are very commonly applied as cell carriers for different approaches in regenerative medicine. HA itself is a well-studied biomolecule that originates from the physiological extracellular matrix (ECM) of mammalians and, due to its acidic polysaccharide structure, offers many different possibilities for suitable chemical modifications which are necessary to control, for example, network formation. Most of these chemical modifications are performed using the free acid function of the polymer and, additionally, lead to an undesirable breakdown of the biopolymer's backbone. An alternative modification of the vicinal diol of the glucuronic acid is oxidation with sodium periodate to generate dialdehydes via a ring opening mechanism that can subsequently be further modified or crosslinked via Schiff base chemistry. Since this oxidation causes a structural destruction of the polysaccharide backbone, it was our intention to study a novel synthesis protocol frequently applied to selectively oxidize the C6 hydroxyl group of saccharides. On the basis of this TEMPO/TCC oxidation, we studied an alternative hydrogel platform based on oxidized HA crosslinked using adipic acid dihydrazide as the crosslinker.

Identifiants

pubmed: 34641507
pii: molecules26195963
doi: 10.3390/molecules26195963
pmc: PMC8512827
pii:
doi:

Substances chimiques

Adipates 0
CD44 protein, human 0
Cross-Linking Reagents 0
Cyclic N-Oxides 0
Hyaluronan Receptors 0
Hydrogels 0
Schiff Bases 0
Hyaluronic Acid 9004-61-9
adipic dihydrazide VK98I9YW5M
TEMPO VQN7359ICQ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 326998133
Organisme : European Regional Development Fund

Références

Materials (Basel). 2016 May 17;9(5):
pubmed: 28773501
Dev Biol. 1986 Apr;114(2):504-18
pubmed: 3514321
Adv Drug Deliv Rev. 2009 Oct 5;61(12):1007-19
pubmed: 19651166
Adv Healthc Mater. 2015 Jan 7;4(1):29-39
pubmed: 25044502
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Control Release. 2006 Mar 10;111(1-2):219-27
pubmed: 16458987
React Funct Polym. 2018 Oct;131:29-35
pubmed: 32256185
Biomaterials. 2013 Jan;34(2):413-21
pubmed: 23084553
Adv Mater. 2017 Nov;29(44):
pubmed: 29044686
Adv Mater. 2013 Jun 4;25(21):2937-42
pubmed: 23495015
Adv Mater. 2015 Sep 9;27(34):5075-9
pubmed: 26177925
Carbohydr Res. 2000 Aug 7;327(4):455-61
pubmed: 10990031
J Biomed Mater Res. 2001 Jan;54(1):115-21
pubmed: 11077410
Macromol Biosci. 2018 Jul;18(7):e1700390
pubmed: 29782701
Angew Chem Int Ed Engl. 2008;47(39):7523-6
pubmed: 18712739
Adv Healthc Mater. 2020 Aug;9(15):e2000737
pubmed: 32757263
Biofabrication. 2017 Nov 14;9(4):044108
pubmed: 28906257
J Mater Chem B. 2017;5(41):8183-8192
pubmed: 29354263
Biomaterials. 2009 Sep;30(26):4287-96
pubmed: 19464053
Osteoarthritis Cartilage. 2010 Oct;18 Suppl 3:S113-6
pubmed: 20864017
Ann Biomed Eng. 1999 Sep-Oct;27(5):656-62
pubmed: 10548335
Biomaterials. 2011 Sep;32(27):6456-70
pubmed: 21680016
Osteoarthritis Cartilage. 2009 Dec;17(12):1639-48
pubmed: 19631307
Gels. 2018 Oct 09;4(4):
pubmed: 30674858
Cell. 1990 Jun 29;61(7):1303-13
pubmed: 1694723
Biochim Biophys Acta. 1986 Sep 4;883(2):173-7
pubmed: 3091074
Mol Cell. 2004 Feb 27;13(4):483-96
pubmed: 14992719
Arch Biochem Biophys. 1961 May;93:440-7
pubmed: 13786180
Biomaterials. 2011 Jan;32(1):39-47
pubmed: 20933268
J Biomed Mater Res A. 2008 May;85(2):352-65
pubmed: 17688243
Biotechnol Lett. 2007 Jan;29(1):17-25
pubmed: 17091377
J Clin Invest. 1994 Apr;93(4):1722-32
pubmed: 7512992
Adv Mater. 2011 Mar 25;23(12):H41-56
pubmed: 21394792
Chem Rev. 2011 Aug 10;111(8):4453-74
pubmed: 21417222
Chem Rev. 2001 Jul;101(7):1869-79
pubmed: 11710233
J Photochem Photobiol B. 1989 Oct;4(1):21-34
pubmed: 2509659
J Biomed Mater Res A. 2018 Apr;106(4):865-875
pubmed: 29314616
J Control Release. 2007 May 14;119(1):5-24
pubmed: 17382422
Biomaterials. 2019 Nov;222:119451
pubmed: 31480001

Auteurs

Junwen Shan (J)

Department of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute (BPI), University of Würzburg, 297070 Würzburg, Germany.

Thomas Böck (T)

Department of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute (BPI), University of Würzburg, 297070 Würzburg, Germany.

Thorsten Keller (T)

Department of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute (BPI), University of Würzburg, 297070 Würzburg, Germany.

Leonard Forster (L)

Department of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute (BPI), University of Würzburg, 297070 Würzburg, Germany.

Torsten Blunk (T)

Department of Trauma, Hand, Plastic and Reconstructive Surgery, University of Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.

Jürgen Groll (J)

Department of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute (BPI), University of Würzburg, 297070 Würzburg, Germany.

Jörg Teßmar (J)

Department of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute (BPI), University of Würzburg, 297070 Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH